You just read:

Transcept Pharmaceuticals Announces that ISS Proxy Advisory Services Recommends "AGAINST" All Proposals Subject to a Vote at the December 19, 2013 Special Meeting of Stockholders

News provided by

Transcept Pharmaceuticals, Inc.

Dec 11, 2013, 04:36 ET